FR2478468A1 - Compositions a base de hyaluronates et preparations cosmetiques les contenant - Google Patents
Compositions a base de hyaluronates et preparations cosmetiques les contenant Download PDFInfo
- Publication number
- FR2478468A1 FR2478468A1 FR8105489A FR8105489A FR2478468A1 FR 2478468 A1 FR2478468 A1 FR 2478468A1 FR 8105489 A FR8105489 A FR 8105489A FR 8105489 A FR8105489 A FR 8105489A FR 2478468 A1 FR2478468 A1 FR 2478468A1
- Authority
- FR
- France
- Prior art keywords
- skin
- molecular weight
- water
- hyaluronate
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 21
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 title abstract description 10
- 239000002537 cosmetic Substances 0.000 title abstract description 10
- 229940014041 hyaluronate Drugs 0.000 title abstract description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 25
- 102000004169 proteins and genes Human genes 0.000 abstract description 12
- 108090000623 proteins and genes Proteins 0.000 abstract description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 abstract description 7
- 229940010747 sodium hyaluronate Drugs 0.000 abstract description 7
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 abstract description 7
- 230000032683 aging Effects 0.000 abstract description 3
- 239000005445 natural material Substances 0.000 abstract description 3
- 239000000470 constituent Substances 0.000 abstract description 2
- 238000005461 lubrication Methods 0.000 abstract description 2
- 230000000295 complement effect Effects 0.000 abstract 1
- 230000036571 hydration Effects 0.000 abstract 1
- 238000006703 hydration reaction Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 24
- 210000004027 cell Anatomy 0.000 description 11
- 239000000126 substance Substances 0.000 description 9
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 239000003974 emollient agent Substances 0.000 description 6
- 239000002304 perfume Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 150000005846 sugar alcohols Chemical class 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 3
- 230000001408 fungistatic effect Effects 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 150000004804 polysaccharides Chemical class 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 229940031439 squalene Drugs 0.000 description 3
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 3
- 210000000434 stratum corneum Anatomy 0.000 description 3
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 206010058667 Oral toxicity Diseases 0.000 description 2
- 229920001586 anionic polysaccharide Polymers 0.000 description 2
- 150000004836 anionic polysaccharides Chemical class 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 231100000418 oral toxicity Toxicity 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-M 4-hydroxybenzoate Chemical group OC1=CC=C(C([O-])=O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-M 0.000 description 1
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-M 9-cis,12-cis-Octadecadienoate Chemical group CCCCC\C=C/C\C=C/CCCCCCCC([O-])=O OYHQOLUKZRVURQ-HZJYTTRNSA-M 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010059516 Skin toxicity Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- -1 anionic saccharide Chemical class 0.000 description 1
- 239000000022 bacteriostatic agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- NEUSVAOJNUQRTM-UHFFFAOYSA-N cetylpyridinium Chemical compound CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 NEUSVAOJNUQRTM-UHFFFAOYSA-N 0.000 description 1
- 229960004830 cetylpyridinium Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 231100000481 chemical toxicant Toxicity 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 210000003717 douglas' pouch Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000007684 eye toxicity Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 210000000554 iris Anatomy 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229940049918 linoleate Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- QZIQJVCYUQZDIR-UHFFFAOYSA-N mechlorethamine hydrochloride Chemical compound Cl.ClCCN(C)CCCl QZIQJVCYUQZDIR-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 231100000327 ocular toxicity Toxicity 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 231100000438 skin toxicity Toxicity 0.000 description 1
- YYGNTYWPHWGJRM-AAJYLUCBSA-N squalene group Chemical group CC(C)=CCC\C(\C)=C\CC\C(\C)=C\CC\C=C(/C)\CC\C=C(/C)\CCC=C(C)C YYGNTYWPHWGJRM-AAJYLUCBSA-N 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 210000004127 vitreous body Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/133,481 US4303676A (en) | 1980-03-21 | 1980-03-21 | Hyaluronate based compositions and cosmetic formulations containing same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2478468A1 true FR2478468A1 (fr) | 1981-09-25 |
| FR2478468B1 FR2478468B1 (US08063081-20111122-C00115.png) | 1984-02-03 |
Family
ID=22458816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR8105489A Granted FR2478468A1 (fr) | 1980-03-21 | 1981-03-19 | Compositions a base de hyaluronates et preparations cosmetiques les contenant |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4303676A (US08063081-20111122-C00115.png) |
| DE (1) | DE3125260A1 (US08063081-20111122-C00115.png) |
| FR (1) | FR2478468A1 (US08063081-20111122-C00115.png) |
| GB (1) | GB2099826B (US08063081-20111122-C00115.png) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0084157A2 (en) * | 1981-12-28 | 1983-07-27 | Sansho Seiyaku Co., Ltd. | Cosmetics |
| FR2565489A1 (fr) * | 1984-06-11 | 1985-12-13 | Biomatrix Inc | Compositions a base de hyaluronate et de polyoxyethylene, et formulations cosmetiques en faisant application |
| EP0244757A2 (en) * | 1986-05-01 | 1987-11-11 | Kabushiki Kaisha Yakult Honsha | Novel production process of hyaluronic acid and bacterium strain therefor as well as cosmetic composition containing hyaluronic acid |
| EP0280807A1 (en) * | 1986-12-11 | 1988-09-07 | Biomatrix, Inc. | Hyaluronate or hylan poly(ethylene oxide) mixtures |
| FR2642971A1 (fr) * | 1989-02-10 | 1990-08-17 | Sterivet Lab Ltd | Preparation cosmetique et procede de fabrication de cette preparation |
| US4957744A (en) * | 1986-10-13 | 1990-09-18 | Fidia, S.P.A. | Cross-linked esters of hyaluronic acid |
| GR890100564A (el) * | 1988-09-09 | 1990-10-31 | Auge Pier Sa | Υδατική γέλη με βάση το υαλουρονικό το οξύ και το δεσοξυριβοζονουκλεϊνικό οξύ, χρησιμοποίηση στην κοσμητική και μέ?οδος παρασκευής της. |
| EP0426074A2 (en) * | 1989-10-30 | 1991-05-08 | Union Carbide Chemicals And Plastics Company, Inc. | Polymer mixtures useful in skin care |
| WO1993015744A1 (en) * | 1992-02-10 | 1993-08-19 | Allergan, Inc. | Bimodal molecular weight hyaluronate formulations and methods for using same |
| US5492936A (en) * | 1990-11-30 | 1996-02-20 | Allergan, Inc. | Bimodal molecular weight hyaluronate formulations and methods for using same |
| WO2009066102A1 (en) * | 2007-11-19 | 2009-05-28 | Burdica Biomed Limited | Vaginal lubricant comprising hyaluronic acid |
| FR2977494A1 (fr) * | 2011-07-08 | 2013-01-11 | Ayawane | Compositions cosmetiques ou pharmaceutiques contenant des acides hyaluroniques de masses moleculaires differentes |
Families Citing this family (81)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1212892B (it) * | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
| IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
| US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
| US4517295A (en) * | 1983-02-18 | 1985-05-14 | Diagnostic, Inc. | Hyaluronic acid from bacterial culture |
| EP0138572B1 (en) * | 1983-10-11 | 1990-07-25 | FIDIA S.p.A. | Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same |
| US5316926A (en) * | 1983-11-25 | 1994-05-31 | Miles Inc. | Method for the microbiological production of non-antigenic hyaluronic acid |
| NO161573C (no) | 1983-11-25 | 1989-08-30 | Miles Inc | Fremgangsmaate til fremstilling av hyaluronsyre. |
| AU3619984A (en) * | 1984-04-23 | 1985-11-15 | Diagnostic Inc. | Hyaluronic acid/hyaluronate based fragrance products |
| US4801475A (en) * | 1984-08-23 | 1989-01-31 | Gregory Halpern | Method of hydrophilic coating of plastics |
| US5340579A (en) * | 1984-11-20 | 1994-08-23 | Farmaka S.R.L. | Method of treating dermatological conditions |
| US5128326A (en) * | 1984-12-06 | 1992-07-07 | Biomatrix, Inc. | Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same |
| US4582865A (en) * | 1984-12-06 | 1986-04-15 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US4636524A (en) * | 1984-12-06 | 1987-01-13 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US4605691A (en) * | 1984-12-06 | 1986-08-12 | Biomatrix, Inc. | Cross-linked gels of hyaluronic acid and products containing such gels |
| US4780414A (en) * | 1985-01-18 | 1988-10-25 | Bio-Technology General Corp. | Method of producing high molecular weight sodium hyallronate by fermentation of streptococcus |
| US4713448A (en) * | 1985-03-12 | 1987-12-15 | Biomatrix, Inc. | Chemically modified hyaluronic acid preparation and method of recovery thereof from animal tissues |
| US5099013A (en) * | 1985-03-12 | 1992-03-24 | Biomatrix, Inc, | Hylan preparation and method of recovery thereof from animal tissues |
| US4663233A (en) * | 1985-10-24 | 1987-05-05 | Universal High Technologies | Lens with hydrophilic coating |
| US5079236A (en) * | 1987-05-27 | 1992-01-07 | Hyal Pharmaceutical Corporation | Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use |
| GB8713747D0 (en) * | 1987-06-12 | 1987-07-15 | Unilever Plc | Skin treatment composition |
| HU203372B (en) | 1989-02-24 | 1991-07-29 | Richter Gedeon Vegyeszet | Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient |
| US4973473A (en) * | 1989-06-23 | 1990-11-27 | Revlon, Inc. | Skin care preparation |
| US6271216B1 (en) | 1989-07-24 | 2001-08-07 | Allergan | Stable solution of hyaluronate in a balanced salt medium |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5102783A (en) * | 1990-01-12 | 1992-04-07 | Vetrepharm, Inc. | Composition and method for culturing and freezing cells and tissues |
| US4988503A (en) * | 1990-01-24 | 1991-01-29 | Revlon, Inc. | Oil-in-water emulsions for foundation makeup composition |
| US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5824658A (en) * | 1990-09-18 | 1998-10-20 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
| US5639738A (en) * | 1992-02-20 | 1997-06-17 | Hyal Pharmaceutical Corporation | Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs |
| US5990096A (en) * | 1990-09-18 | 1999-11-23 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
| US5234914A (en) * | 1991-06-11 | 1993-08-10 | Patent Biopharmaceutics, Inc. | Methods of treating hemorrhoids and anorecial disease |
| US6022866A (en) * | 1991-07-03 | 2000-02-08 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5817644A (en) * | 1991-07-03 | 1998-10-06 | Hyal Pharmaceutical Corporation | Targeting of dosages of medicine and therapeutic agents |
| US6103704A (en) * | 1991-07-03 | 2000-08-15 | Hyal Pharmaceutical Corporation | Therapeutic methods using hyaluronic acid |
| US5990095A (en) * | 1991-07-03 | 1999-11-23 | Hyal Pharmaceutical Corporation | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US5977088A (en) * | 1991-07-03 | 1999-11-02 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5792753A (en) * | 1991-07-03 | 1998-08-11 | Hyal Pharmaceutical Corporation | Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs |
| WO1994007505A1 (en) * | 1991-07-03 | 1994-04-14 | Norpharmco Inc. | Use of hyaluronic acid and forms to prevent arterial restenosis |
| US6218373B1 (en) | 1992-02-20 | 2001-04-17 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| US5942498A (en) * | 1992-02-20 | 1999-08-24 | Hyal Pharmaceutical Corporation | Formulations containing hyaluronic acid |
| CA2061567C (en) * | 1992-02-20 | 1998-02-03 | Rudolf E. Falk | Use of hyaluronic acid to repair ischemia reperfusion damage |
| US6114314A (en) * | 1992-02-21 | 2000-09-05 | Hyal Pharmaceutical Corp. | Formulations containing hyaluronic acid |
| US5767106A (en) * | 1992-02-21 | 1998-06-16 | Hyal Pharmaceutical Corporation | Treatment of disease and conditions associated with macrophage infiltration |
| US5358706A (en) * | 1992-09-30 | 1994-10-25 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| US5645827A (en) * | 1992-09-30 | 1997-07-08 | Union Carbide Chemicals & Plastics Technology Corporation | Muco-adhesive polymers |
| IL114193A (en) * | 1994-06-20 | 2000-02-29 | Teva Pharma | Ophthalmic pharmaceutical compositions based on sodium alginate |
| WO1996004922A1 (en) * | 1994-08-10 | 1996-02-22 | Davis, Joanne, T. | Method of using hyaluronic acid for the detection, location and diagnosis of tumors |
| US5770711A (en) * | 1996-09-30 | 1998-06-23 | Kimberly-Clark Worldwide, Inc. | Polysaccharides substituted with polycarboxylated moieties |
| JP2002533376A (ja) * | 1998-12-23 | 2002-10-08 | エスパルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング | ヒアルロン酸から加水分解によって製造されたフラグメント混合物を含有する皮膚保護剤 |
| ATE245452T1 (de) | 1998-12-23 | 2003-08-15 | Esparma Gmbh | Hyaluronatlyase als penetrationsförderer in topischen mitteln |
| AU2745700A (en) | 1999-02-01 | 2000-08-18 | Dermal Research Laboratories, Inc. | A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same |
| US7879824B2 (en) | 2001-07-31 | 2011-02-01 | Dermal Research Laboratories, Inc. | Methods of preventing or treating diseases and conditions using complex carbohydrates |
| US7635489B2 (en) * | 2001-05-18 | 2009-12-22 | Leneau Holdings, Llc | Ingestion of hyaluronic acid for improved joint health |
| US6806259B2 (en) | 2001-12-21 | 2004-10-19 | Soft Gel Technologies, Inc. | Hyaluronic Acid in soft gel form |
| ITMI20021866A1 (it) * | 2002-08-30 | 2004-02-29 | Luigi Allegra | Preparazione farmaceutica in forma colloidale utile nella cura delle affezioni cutanee. |
| DE10246340A1 (de) * | 2002-10-04 | 2004-04-29 | Wohlrab, David, Dr. | Kombinationspräparat aus Hyaluronsäure und mindestens einem Lokalanästhetikum und dessen Verwendung |
| LT5098B (lt) | 2003-03-28 | 2004-01-26 | Alvyda GUDELEVIČIŪTĖ | Kremų kompozicijos senstančiai odai |
| CN100333804C (zh) * | 2003-04-18 | 2007-08-29 | 上海建华精细生物制品有限公司 | 透明质酸钠防粘连薄膜及其制备方法 |
| FR2865651B1 (fr) * | 2004-01-29 | 2007-09-28 | Fabre Pierre Dermo Cosmetique | Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale |
| US20050180938A1 (en) * | 2004-02-17 | 2005-08-18 | Beatrice Novelli | Skin care cosmetic regime and kit |
| EP1595528A1 (de) * | 2004-05-14 | 2005-11-16 | Fibona Health Products GmbH | Hyaferm-Komposite |
| WO2005113608A1 (en) * | 2004-05-20 | 2005-12-01 | Mentor Corporation | Method of covalently linking hyaluronan and chitosan |
| US20050281880A1 (en) * | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
| US20070059276A1 (en) * | 2005-09-07 | 2007-03-15 | Amo Regional Holdings | Bi-modal hyaluronate |
| FR2895907B1 (fr) | 2006-01-06 | 2012-06-01 | Anteis Sa | Gel viscoelastique a usage dermatologique |
| JP2009536625A (ja) * | 2006-05-11 | 2009-10-15 | ゴッボ・サンドラ | ヒアルロン酸二成分混合物、その医療での使用 |
| WO2008000260A1 (en) * | 2006-06-28 | 2008-01-03 | Novozymes Biopolymer A/S | Compositions with several hyaluronic acid fractions for cosmetic and medical uses |
| WO2008003321A2 (en) * | 2006-07-07 | 2008-01-10 | Novozymes Biopolymer A/S | Compositions with several hyaluronic acid fractions for cosmetic use |
| GB0614353D0 (en) | 2006-07-20 | 2006-08-30 | Oraldent Ltd | Oral compositions, their preparation and use |
| JP5740087B2 (ja) * | 2006-09-13 | 2015-06-24 | エンハンス スキン プロダクツ，インク． | スキンケア用化粧品組成物およびその製造方法 |
| FR2919185B1 (fr) * | 2007-07-23 | 2010-09-10 | Ard Sa | Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses |
| FR2924606B1 (fr) * | 2007-12-10 | 2010-08-13 | Jean Noel Thorel | Composition a base d'acide hyaluronique pour l'hydratation de la peau. |
| ITMI20080636A1 (it) * | 2008-04-10 | 2009-10-11 | Biophil S R L | Patch per uso dermico |
| EP2343078A4 (en) * | 2008-09-30 | 2012-05-16 | Denki Kagaku Kogyo Kk | PHARMACEUTICAL COMPOSITION STABILIZED BY LIGHT |
| US8624077B2 (en) | 2008-10-02 | 2014-01-07 | L.R.R.&D. Ltd. | Interface layer wound dressing |
| IT1397246B1 (it) | 2009-05-14 | 2013-01-04 | Fidia Farmaceutici | Nuovi medicamenti ad uso topico a base di acido ialuronico solfatato come agente attivante o inibente l'attivita' citochinica |
| FR2963240B1 (fr) * | 2010-07-28 | 2013-03-15 | Horus Pharma | Composition a usage topique sans conservateur comprenant de l'acide hyaluronique |
| KR101577127B1 (ko) | 2011-06-09 | 2015-12-11 | 산요가세이고교 가부시키가이샤 | 다당의 제조 방법 |
| CN104473857B (zh) * | 2014-11-24 | 2017-05-24 | 广州神采化妆品有限公司 | 一种炫彩啫喱及其制备方法 |
| IT201900024208A1 (it) * | 2019-12-17 | 2021-06-17 | Altergon Sa | Miscele iniettabili di acido ialuronico per uso in dermoestetica |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1792514A1 (de) * | 1967-09-14 | 1970-01-02 | Prephar Prospection De Rech S | Kosmetische Hautpraeparate,natuerliche Substanzen,Glucidamide genannt,enthaltend |
| FR2094109A7 (US08063081-20111122-C00115.png) * | 1970-06-08 | 1972-02-04 | Lubowe Irwin | |
| US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
| JPS5452733A (en) * | 1977-10-04 | 1979-04-25 | Pola Kasei Kogyo Kk | Skin cosmetics |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3659025A (en) * | 1966-04-28 | 1972-04-25 | Pillsbury Co | Cosmetic compositions employing water-soluble polysaccharides |
| US4151304A (en) * | 1976-11-05 | 1979-04-24 | Lever Brothers Company | Method and composition for moisturizing the skin |
-
1980
- 1980-03-21 US US06/133,481 patent/US4303676A/en not_active Expired - Lifetime
-
1981
- 1981-03-19 FR FR8105489A patent/FR2478468A1/fr active Granted
- 1981-06-04 GB GB8117153A patent/GB2099826B/en not_active Expired
- 1981-06-26 DE DE19813125260 patent/DE3125260A1/de active Granted
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1792514A1 (de) * | 1967-09-14 | 1970-01-02 | Prephar Prospection De Rech S | Kosmetische Hautpraeparate,natuerliche Substanzen,Glucidamide genannt,enthaltend |
| FR2094109A7 (US08063081-20111122-C00115.png) * | 1970-06-08 | 1972-02-04 | Lubowe Irwin | |
| US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
| US4141973B1 (US08063081-20111122-C00115.png) * | 1975-10-17 | 1989-08-08 | ||
| JPS5452733A (en) * | 1977-10-04 | 1979-04-25 | Pola Kasei Kogyo Kk | Skin cosmetics |
Non-Patent Citations (1)
| Title |
|---|
| CHEMICAL ABSTRACTS, vol. 91, no. 26, 24 décembre 1979, réf. 216677c, page 332, COLUMBUS, OHIO, (US); & JP - A - 79 52 733 (POLAR CHEMICALS LTD.) (25 avril 1979). * |
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0084157A2 (en) * | 1981-12-28 | 1983-07-27 | Sansho Seiyaku Co., Ltd. | Cosmetics |
| EP0084157A3 (en) * | 1981-12-28 | 1984-05-09 | Sansho Seiyaku Co., Ltd. | Cosmetics |
| FR2565489A1 (fr) * | 1984-06-11 | 1985-12-13 | Biomatrix Inc | Compositions a base de hyaluronate et de polyoxyethylene, et formulations cosmetiques en faisant application |
| EP0244757A2 (en) * | 1986-05-01 | 1987-11-11 | Kabushiki Kaisha Yakult Honsha | Novel production process of hyaluronic acid and bacterium strain therefor as well as cosmetic composition containing hyaluronic acid |
| EP0244757A3 (en) * | 1986-05-01 | 1988-08-24 | Kabushiki Kaisha Yakult Honsha | Novel production process of hyaluronic acid and bacterium strain therefor as well as cosmetic composition containing hyaluronic acid |
| US5023175A (en) * | 1986-05-01 | 1991-06-11 | Kabushiki Kaisha Yakult Honsha | Novel production process of hyaluronic acid and bacterium strain therefor |
| US4957744A (en) * | 1986-10-13 | 1990-09-18 | Fidia, S.P.A. | Cross-linked esters of hyaluronic acid |
| EP0280807A1 (en) * | 1986-12-11 | 1988-09-07 | Biomatrix, Inc. | Hyaluronate or hylan poly(ethylene oxide) mixtures |
| GR890100564A (el) * | 1988-09-09 | 1990-10-31 | Auge Pier Sa | Υδατική γέλη με βάση το υαλουρονικό το οξύ και το δεσοξυριβοζονουκλεϊνικό οξύ, χρησιμοποίηση στην κοσμητική και μέ?οδος παρασκευής της. |
| FR2642971A1 (fr) * | 1989-02-10 | 1990-08-17 | Sterivet Lab Ltd | Preparation cosmetique et procede de fabrication de cette preparation |
| EP0426074A2 (en) * | 1989-10-30 | 1991-05-08 | Union Carbide Chemicals And Plastics Company, Inc. | Polymer mixtures useful in skin care |
| EP0426074A3 (en) * | 1989-10-30 | 1991-10-30 | Union Carbide Chemicals And Plastics Company, Inc. | Polymer mixtures useful in skin care |
| US5492936A (en) * | 1990-11-30 | 1996-02-20 | Allergan, Inc. | Bimodal molecular weight hyaluronate formulations and methods for using same |
| US6107347A (en) * | 1990-11-30 | 2000-08-22 | Allergan | Bimodal molecular weight hyaluronate formulations and methods for using same |
| WO1993015744A1 (en) * | 1992-02-10 | 1993-08-19 | Allergan, Inc. | Bimodal molecular weight hyaluronate formulations and methods for using same |
| WO2009066102A1 (en) * | 2007-11-19 | 2009-05-28 | Burdica Biomed Limited | Vaginal lubricant comprising hyaluronic acid |
| US9044387B2 (en) | 2007-11-19 | 2015-06-02 | British Biocell International Limited | Vaginal lubricant comprising hyaluronic acid |
| EP3838277A1 (en) * | 2007-11-19 | 2021-06-23 | BBI Healthcare Limited | Vaginal lubricant comprising hyaluronic acid |
| FR2977494A1 (fr) * | 2011-07-08 | 2013-01-11 | Ayawane | Compositions cosmetiques ou pharmaceutiques contenant des acides hyaluroniques de masses moleculaires differentes |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2099826B (en) | 1984-08-22 |
| DE3125260A1 (de) | 1983-01-20 |
| GB2099826A (en) | 1982-12-15 |
| DE3125260C2 (US08063081-20111122-C00115.png) | 1987-04-09 |
| US4303676A (en) | 1981-12-01 |
| FR2478468B1 (US08063081-20111122-C00115.png) | 1984-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2478468A1 (fr) | Compositions a base de hyaluronates et preparations cosmetiques les contenant | |
| EP1064008B1 (fr) | Utilisation d'au moins un extrait proteique de graines de plantes du genre moringa et composition cosmetique et/ou pharmaceutique correspondante | |
| CA1341321C (fr) | Gel aqueux a base d'acide hyaluronique et d'acide desoxyribonucleique utilisable en cosmetique, et procede de preparation | |
| EP0414608B1 (fr) | Nouvelles compositions cosmétiques contenant du chitosane et de la glucosamine | |
| EP1933808B1 (fr) | Compositions cosmetiques notamment a activite anti-vieillissement comprenant un extrait de la plante aframomum angustifolium ou longoza | |
| FR3065172A1 (fr) | Preparation cosmetique contenant un extrait de truffe blanche et procede cosmetique associe | |
| WO1988009654A1 (fr) | Composition a base d'extrait de murier | |
| FR3111795A1 (fr) | Kit de soin pour les matières kératiniques | |
| EP1530480B1 (fr) | Composition cosmetique comprenant des mono- ou poly-saccharides, utilisations et procedes de traitement | |
| FR3026946A1 (fr) | Utilisation cosmetique d'un extrait de lilium candidum comme agent anti-rougeur et/ou pour ameliorer le lissage de la peau | |
| WO2007144518A2 (fr) | Utilisation d'un extrait de graines de mimosa dans une composition cosmetique | |
| FR2757046A1 (fr) | Utilisation d'un extrait de resine d'okoume, dans les domaines cosmetique et pharmaceutique, notamment dermatologiques | |
| EP0652763B1 (fr) | Extraits bruts d'algues bleues, leurs procedes de preparation et leurs applications en cosmetologie et en dermatologie | |
| EP1569614B1 (fr) | Utilisation d'un extrait de miellat de coton comme ingredient actif | |
| FR2742055A1 (fr) | Melange d'extraits de plantes et leurs utilisations, notamment pour le traitement local symptomatique des surcharges adipeuses sous-cutanees localisees | |
| FR2487197A2 (fr) | Procede ameliore d'extraction et de traitement de glycoproteines et/ou de mucopolysaccharides et de substances qui les accompagnent | |
| FR3040625A1 (fr) | Principe actif cosmetique issu d'helichrysum stoechas et utilisation pour lutter contre le vieillissement de la peau | |
| FR2731351A1 (fr) | Composition pour le lissage de la peau et procede pour la preparation de cette composition | |
| FR3018448A1 (fr) | Principe actif obtenu a partir de l'algue hypnea musciformis et utilisations cosmetiques | |
| FR2945213A1 (fr) | Compositions cosmetiques et dermatologiques et dermatologiques a base d'extrait de silene. | |
| FR2776184A1 (fr) | Composition cosmetique capillaire anti-chute | |
| CA1140469A (en) | Hyaluronate based compositions and cosmetic formulations containing same | |
| EP0754448B1 (fr) | Composition sous forme de poudre auto-émulsionnable dans l'eau | |
| FR2761264A1 (fr) | Utilisation d'extrait(s) de graines de pois bambara dans une composition cosmetique et composition cosmetique correspondante | |
| WO2024074633A1 (fr) | Extrait alcoolique de fleurs lys blanc, lilium candidum l., son procédé d'obtention, et composition cosmétique le contenant |